MAZE - Maze Therapeutics, Inc.
25.81
-0.200 -0.775%
Share volume: 503,984
Last Updated: 04-24-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.22%
PREVIOUS CLOSE
CHG
CHG%
$26.01
-0.20
-0.01%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2025 | 11-06-2025 | 03-25-2026 | |
| Cash flow financing | 127.378 M | 143.757 M | 3.590 M | |
| Other financing cash flows | -374.000 K | 2.009 M | 3.427 M | |
| Cash flow | 97.563 M | 52.232 M | -127.527 M | |
| Net income | -32.786 M | -30.087 M | -34.568 M | |
| Depreciation | 684.000 K | 571.000 K | 499.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -299.000 K | -66.883 M | -103.387 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 299.000 K | 68.000 K | 34.000 K | |
| Cash Change | 97.563 M | 52.232 M | -127.527 M |